Obagi

clenziderm logo CMYK 2748

Obagi CLENZIderm® M.D. Systems are the only prescription-strength acne treatments that contain a patented, solubilized form of 5% benzoyl peroxide (BPO) to penetrate deep into the follicle and treat acne where it starts.
Available in two distinct systems, for normal to oily skin or normal to dry skin, these simple, 3-step, physician-dispensed acne therapies from Obagi Medical are clinically proven to better penetrate the follicles for effective P. acnes bacteria reduction and rapid lesion reduction.*
Ask your skincare professional today which CLENZIderm® M.D. System is right for you, and experience the benefits of CLENZIderm® M.D. Systems
  • Exclusive penetrating technology that delivers BPO to the root of acne
  • Clinically significant lesion reduction in 2 weeks, compared to the leading topical prescription BPO/clindamycin combination
  • Availability of two distinct, prescription-strength formulations for a broad range of skin types

*Postered at the 2007 Annual American Academy of Dermatology Meeting. Click here to view full study

Categories


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